Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,225 JPY | +3.99% | +3.99% | +7.74% |
2023 | Fumakilla Limited Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2022 | Fumakilla Limited(TSE:4998) dropped from S&P Global BMI Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company appears to be poorly valued given its net asset value.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- The company is highly valued given the cash flows generated by its activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.74% | 125M | - | ||
+2.08% | 3.61B | C- | ||
-19.91% | 2.15B | C+ | ||
-7.20% | 1.95B | B- | ||
+2.34% | 1.9B | - | ||
+1.54% | 1.71B | - | ||
-3.83% | 1.3B | B | ||
+3.39% | 1.19B | - | ||
-18.55% | 1.06B | - | ||
+2.18% | 1.06B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4998 Stock
- Ratings Fumakilla Limited